These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28268072)

  • 21. Role of pharmacist-provided point of care testing.
    Kuhn CH
    J Am Pharm Assoc (2003); 2015; 55(6):572-573. PubMed ID: 26547594
    [No Abstract]   [Full Text] [Related]  

  • 22. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of medication reviews by community pharmacists.
    Kolhatkar A; Cheng L; Chan FK; Harrison M; Law MR
    J Am Pharm Assoc (2003); 2016; 56(5):513-520.e1. PubMed ID: 27594104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies and steps fostering the success of medication management services in community pharmacies.
    Pestka DL; Frail CK; Palombi LC; Von Hoff BA; Conway JM; Sorensen TD
    J Am Pharm Assoc (2003); 2016; 56(5):504-512.e1. PubMed ID: 27498311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting. A case report.
    Garcia-Cardenas V; Benrimoj SI; Ocampo CC; Goyenechea E; Martinez-Martinez F; Gastelurrutia MA
    Res Social Adm Pharm; 2017; 13(3):614-627. PubMed ID: 27423785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community pharmacists preventing hospital readmissions.
    Clay PG
    J Am Pharm Assoc (2003); 2014; 54(2):208. PubMed ID: 24632935
    [No Abstract]   [Full Text] [Related]  

  • 28. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
    Emmerton L
    J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the economic impact of a targeted medication intervention program.
    Rhodes SA; Reynolds AE; Marciniak MW; Ferreri SP
    J Pharm Pract; 2013 Dec; 26(6):562-73. PubMed ID: 23804242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the effect of providing a pharmacist with patient diagnosis on electronic prescription orders: a pilot study.
    Warholak TL; Rupp MT; Leal S; Kurniawan G; Patel N
    Res Social Adm Pharm; 2014; 10(1):246-51. PubMed ID: 23688539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription Adaptation Services: A Regulatory and Practice Perspective.
    Adams AJ
    Ann Pharmacother; 2018 Jul; 52(7):700-703. PubMed ID: 29514463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community Pharmacists' Perspectives on Dispensing Medications With the Potential for Misuse, Diversion, and Intentional Overdose: Results of a Province-Wide Survey of Community Pharmacists in Canada.
    Leong C; Alessi-Severini S; Sareen J; Enns MW; Bolton J
    Subst Use Misuse; 2016 Nov; 51(13):1724-30. PubMed ID: 27487323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing inappropriate use of non-prescription combination analgesics containing codeine: A modified Delphi study.
    Gibbins AK; Wood PJ; Spark MJ
    Res Social Adm Pharm; 2017; 13(2):369-377. PubMed ID: 27084506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of Community Pharmacists in Transition of Care (TOC) Services: Current Trends and Pharmacist Perceptions.
    Zeleznikar EA; Kroehl ME; Perica KM; Thompson AM; Trinkley KE
    J Pharm Pract; 2019 Feb; 32(1):28-35. PubMed ID: 29061080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Columbus Air Force Base medication profile intervention practice innovation.
    Guill JV; Griffin LA; Goodwin TD
    J Am Pharm Assoc (2003); 2008; 48(5):654-8. PubMed ID: 18826905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can a pharmacist reduce annual costs for Medicare Part D enrollees?
    Alston G; Hanrahan C
    Consult Pharm; 2011 Mar; 26(3):182-9. PubMed ID: 21402518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy.
    Nusair MB; Guirguis LM
    Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.